Influence of Vertical Implant Position on Marginal Bone Loss in Cases With Thin Phenotype

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCairo University

About this trial

The goal of this clinical trial is to learn if vertical position of the dental implant will affect the bone around the implant in place of a missing tooth that happens to be bounded by two natural teeth. It will also measure esthetics and patient satisfaction. The main questions it aims to answer are:

Does vertical implant position below the crest of the bone lead to less marginal bone loss? Will it affect implant survival as well as quality of soft tissue, esthetics and patient satisfaction?

Participants will:

Have an implant placed at the bone level or 2 mm below the bone level Visit the clinic once every 3 months for checkups, radiographs, and readings

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with single missing upper anterior or premolar teeth

Patients with minimum buccolingual width of 6 mm and mesiodistal width of 6 mm

Patients with thin soft tissue phenotype

Patients with healthy systemic conditions.

Disqualifiers

Patients with inadequate bone volume and/ or quality

Patients with local root remnants

Patients with inadequate wound healing

Patients with signs of acute infection related to the area of interest.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Delayed implant with immediate temporization placed 2 mm subcrestal level

    Procedure/Surgery

    2 mm subcrestal placement

  • Delayed implant with immediate temporization placed at the crestal level

    Procedure/Surgery

    crestal level placement

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Delayed implant with immediate temporization placed 2 mm subcrestal levelExperimental treatment 1 intervention
Group B: Delayed implant with immediate temporization placed at crestal bone levelActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Marginal bone loss (crestal bone loss)

measured linearly in mm by comparing periapical radiographs

Time frame
Assessment at baseline, 3 months post-operative, 6 months post-operative, 9 months post-operative and 12 months post-operative

Secondary outcomes

1

Midfacial recession

Corono-apical distance measured from the incisal edge/cusp tip to the peri-implant soft tissue margin

Time frame
0, 3, 6, 9, 12 months post-operative
2

Pink Esthetic Score (PES)

The pink esthetic score will be calculated on the parameters defined by (Fürhauser et al. 2005). Clinical photographs will be taken to evaluate peri-implant soft tissue through evaluating seven variables compared to a natural reference tooth including: mesial papilla, distal papilla, soft tissue level, soft tissue contour, alveolar process deficiency, soft tissue color and soft tissue texture, all using a 0-1-2 scoring system, 0 being the lowest and 2 the highest value. The maximum achievable PES is 14.

Time frame
baseline, 3, 6, 9, 12 months post-operative
3

Gingival thickness

Gingival thickness will be measured using an anesthetic needle with a rubber stopper, trans-gingivally piercing tissues horizontally perpendicular to the long axis of the tooth/implant until the needle contacts bone, at 3 different points. Three readings will be taken mid-buccally at three different levels; 2 mm, 4 mm and 6 mm apical to the gingival margin. The length of the part of the instrument that penetrates into the soft tissue is measured in mm using a caliper.

Time frame
baseline, 3, 6, 9, 12 months post-operative
4

Implant survival

A binary outcome, the definition of implant success was based on the clinical and radiographic criteria described by Buser et al. 1990; 1) absence of clinically detectable implant mobility; 2) absence of pain or any subjective sensation; 3) absence of recurrent peri-implant infection; and 4) absence of persistent radiolucency around the implant after 12 months of loading (Buser, Weber and Lang, 1990)

Time frame
12 months post-operative

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.